0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tuberculosis Vaccine Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Othe-1166
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Tuberculosis Vaccine Treatment Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Tuberculosis Vaccine Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Othe-1166
Report
August 2021
125 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
Market Analysis and Insights: Global Tuberculosis Vaccine Treatment Market

In 2020, the global Tuberculosis Vaccine Treatment market size was US$ 72 million and it is expected to reach US$ 87 million by the end of 2027, with a CAGR of 2.9% during 2021-2027.

Global Tuberculosis Vaccine Treatment Scope and Market Size
Tuberculosis Vaccine Treatment market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Tuberculosis Vaccine Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Tuberculosis Vaccine Treatment market is segmented into

Immune Vaccine
Therapy Vaccine

Segment by Application, the Tuberculosis Vaccine Treatment market is segmented into

Self-Procurement
UNICEF
Other
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Tuberculosis Vaccine Treatment Market Share Analysis
Tuberculosis Vaccine Treatment market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Tuberculosis Vaccine Treatment product introduction, recent developments, Tuberculosis Vaccine Treatment sales by region, type, application and by sales channel.
The major companies include:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
1 Study Coverage
1.1 Tuberculosis Vaccine Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market by Application
1.3.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Vaccine Treatment Market Size Estimates and Forecasts
2.1.1 Global Tuberculosis Vaccine Treatment Revenue 2016-2027
2.1.2 Global Tuberculosis Vaccine Treatment Sales 2016-2027
2.2 Tuberculosis Vaccine Treatment Market Size by Region: 2021 Versus 2027
2.3 Tuberculosis Vaccine Treatment Sales by Region (2016-2027)
2.3.1 Global Tuberculosis Vaccine Treatment Sales by Region: 2016-2021
2.3.2 Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2022-2027)
2.3.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2027)
2.4 Tuberculosis Vaccine Treatment Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Tuberculosis Vaccine Treatment Revenue by Region: 2016-2021
2.4.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2022-2027)
2.4.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2027)
3 Global Tuberculosis Vaccine Treatment by Manufacturers
3.1 Global Top Tuberculosis Vaccine Treatment Manufacturers by Sales
3.1.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturer (2016-2021)
3.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Tuberculosis Vaccine Treatment Manufacturers by Revenue
3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Manufacturer (2016-2021)
3.2.2 Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturer (2016-2021)
3.3 Global Tuberculosis Vaccine Treatment Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Tuberculosis Vaccine Treatment Manufacturers Covered: Ranking by Revenue
3.4.2 Global Tuberculosis Vaccine Treatment Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Tuberculosis Vaccine Treatment Manufacturing Base Distribution, Product Type
3.5.1 Tuberculosis Vaccine Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Tuberculosis Vaccine Treatment Product Type
3.5.3 Date of International Manufacturers Enter into Tuberculosis Vaccine Treatment Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merck
4.1.1 Merck Corporation Information
4.1.2 Merck Description, Business Overview
4.1.3 Merck Tuberculosis Vaccine Treatment Products Offered
4.1.4 Merck Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Merck Tuberculosis Vaccine Treatment Revenue by Product
4.1.6 Merck Tuberculosis Vaccine Treatment Revenue by Application
4.1.7 Merck Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.1.8 Merck Tuberculosis Vaccine Treatment Revenue by Sales Channel
4.1.9 Merck Recent Development
4.2 Japan BCG Lab
4.2.1 Japan BCG Lab Corporation Information
4.2.2 Japan BCG Lab Description, Business Overview
4.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Products Offered
4.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Japan BCG Lab Tuberculosis Vaccine Treatment Revenue by Product
4.2.6 Japan BCG Lab Tuberculosis Vaccine Treatment Revenue by Application
4.2.7 Japan BCG Lab Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.2.8 Japan BCG Lab Tuberculosis Vaccine Treatment Revenue by Sales Channel
4.2.9 Japan BCG Lab Recent Development
4.3 Serum Institute of India
4.3.1 Serum Institute of India Corporation Information
4.3.2 Serum Institute of India Description, Business Overview
4.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Products Offered
4.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Serum Institute of India Tuberculosis Vaccine Treatment Revenue by Product
4.3.6 Serum Institute of India Tuberculosis Vaccine Treatment Revenue by Application
4.3.7 Serum Institute of India Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.3.8 Serum Institute of India Tuberculosis Vaccine Treatment Revenue by Sales Channel
4.3.9 Serum Institute of India Recent Development
4.4 AJ Vaccines
4.4.1 AJ Vaccines Corporation Information
4.4.2 AJ Vaccines Description, Business Overview
4.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Products Offered
4.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.4.5 AJ Vaccines Tuberculosis Vaccine Treatment Revenue by Product
4.4.6 AJ Vaccines Tuberculosis Vaccine Treatment Revenue by Application
4.4.7 AJ Vaccines Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.4.8 AJ Vaccines Tuberculosis Vaccine Treatment Revenue by Sales Channel
4.4.9 AJ Vaccines Recent Development
4.5 BioFarma
4.5.1 BioFarma Corporation Information
4.5.2 BioFarma Description, Business Overview
4.5.3 BioFarma Tuberculosis Vaccine Treatment Products Offered
4.5.4 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.5.5 BioFarma Tuberculosis Vaccine Treatment Revenue by Product
4.5.6 BioFarma Tuberculosis Vaccine Treatment Revenue by Application
4.5.7 BioFarma Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.5.8 BioFarma Tuberculosis Vaccine Treatment Revenue by Sales Channel
4.5.9 BioFarma Recent Development
4.6 GreenSignal Bio Pharma
4.6.1 GreenSignal Bio Pharma Corporation Information
4.6.2 GreenSignal Bio Pharma Description, Business Overview
4.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Products Offered
4.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.6.5 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Revenue by Product
4.6.6 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Revenue by Application
4.6.7 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.6.8 GreenSignal Bio Pharma Recent Development
4.7 China National Biotec
4.7.1 China National Biotec Corporation Information
4.7.2 China National Biotec Description, Business Overview
4.7.3 China National Biotec Tuberculosis Vaccine Treatment Products Offered
4.7.4 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.7.5 China National Biotec Tuberculosis Vaccine Treatment Revenue by Product
4.7.6 China National Biotec Tuberculosis Vaccine Treatment Revenue by Application
4.7.7 China National Biotec Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.7.8 China National Biotec Recent Development
4.8 Biomed Lublin
4.8.1 Biomed Lublin Corporation Information
4.8.2 Biomed Lublin Description, Business Overview
4.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Products Offered
4.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Biomed Lublin Tuberculosis Vaccine Treatment Revenue by Product
4.8.6 Biomed Lublin Tuberculosis Vaccine Treatment Revenue by Application
4.8.7 Biomed Lublin Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.8.8 Biomed Lublin Recent Development
4.9 Taj Pharmaceuticals
4.9.1 Taj Pharmaceuticals Corporation Information
4.9.2 Taj Pharmaceuticals Description, Business Overview
4.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Products Offered
4.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Revenue by Product
4.9.6 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Revenue by Application
4.9.7 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.9.8 Taj Pharmaceuticals Recent Development
4.10 Ataulpho de Paiva
4.10.1 Ataulpho de Paiva Corporation Information
4.10.2 Ataulpho de Paiva Description, Business Overview
4.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Products Offered
4.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Ataulpho de Paiva Tuberculosis Vaccine Treatment Revenue by Product
4.10.6 Ataulpho de Paiva Tuberculosis Vaccine Treatment Revenue by Application
4.10.7 Ataulpho de Paiva Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.10.8 Ataulpho de Paiva Recent Development
4.11 IVAC
4.11.1 IVAC Corporation Information
4.11.2 IVAC Description, Business Overview
4.11.3 IVAC Tuberculosis Vaccine Treatment Products Offered
4.11.4 IVAC Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.11.5 IVAC Tuberculosis Vaccine Treatment Revenue by Product
4.11.6 IVAC Tuberculosis Vaccine Treatment Revenue by Application
4.11.7 IVAC Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.11.8 IVAC Recent Development
4.12 Queen Saovabha Mem. Inst
4.12.1 Queen Saovabha Mem. Inst Corporation Information
4.12.2 Queen Saovabha Mem. Inst Description, Business Overview
4.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Products Offered
4.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Revenue by Product
4.12.6 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Revenue by Application
4.12.7 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.12.8 Queen Saovabha Mem. Inst Recent Development
4.13 Microgen
4.13.1 Microgen Corporation Information
4.13.2 Microgen Description, Business Overview
4.13.3 Microgen Tuberculosis Vaccine Treatment Products Offered
4.13.4 Microgen Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Microgen Tuberculosis Vaccine Treatment Revenue by Product
4.13.6 Microgen Tuberculosis Vaccine Treatment Revenue by Application
4.13.7 Microgen Tuberculosis Vaccine Treatment Revenue by Geographic Area
4.13.8 Microgen Recent Development
5 Breakdown Data by Type
5.1 Global Tuberculosis Vaccine Treatment Sales by Type (2016-2027)
5.1.1 Global Tuberculosis Vaccine Treatment Sales by Type (2016-2021)
5.1.2 Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2022-2027)
5.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027)
5.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2016-2027)
5.2.1 Global Tuberculosis Vaccine Treatment Revenue by Type (2016-2021)
5.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2022-2027)
5.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027)
5.3 Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Tuberculosis Vaccine Treatment Sales by Application (2016-2027)
6.1.1 Global Tuberculosis Vaccine Treatment Sales by Application (2016-2021)
6.1.2 Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2022-2027)
6.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027)
6.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2016-2027)
6.2.1 Global Tuberculosis Vaccine Treatment Revenue by Application (2016-2021)
6.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2022-2027)
6.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027)
6.3 Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Tuberculosis Vaccine Treatment Market Size YoY Growth 2016-2027
7.2 North America Tuberculosis Vaccine Treatment Market Facts & Figures by Country
7.2.1 North America Tuberculosis Vaccine Treatment Sales by Country (2016-2027)
7.2.2 North America Tuberculosis Vaccine Treatment Revenue by Country (2016-2027)
7.3 North America Tuberculosis Vaccine Treatment Sales by Type
7.4 North America Tuberculosis Vaccine Treatment Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Vaccine Treatment Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Tuberculosis Vaccine Treatment Market Facts & Figures by Region
8.2.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2016-2027)
8.2.2 Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2016-2027)
8.3 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type
8.4 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application
9 Europe
9.1 Europe Tuberculosis Vaccine Treatment Market Size YoY Growth 2016-2027
9.2 Europe Tuberculosis Vaccine Treatment Market Facts & Figures by Country
9.2.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2027)
9.2.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2027)
9.3 Europe Tuberculosis Vaccine Treatment Sales by Type
9.4 Europe Tuberculosis Vaccine Treatment Sales by Application
10 Latin America
10.1 Latin America Tuberculosis Vaccine Treatment Market Size YoY Growth 2016-2027
10.2 Latin America Tuberculosis Vaccine Treatment Market Facts & Figures by Country
10.2.1 Latin America Tuberculosis Vaccine Treatment Sales by Country (2016-2027)
10.2.2 Latin America Tuberculosis Vaccine Treatment Revenue by Country (2016-2027)
10.3 Latin America Tuberculosis Vaccine Treatment Sales by Type
10.4 Latin America Tuberculosis Vaccine Treatment Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Tuberculosis Vaccine Treatment Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Tuberculosis Vaccine Treatment Market Facts & Figures by Country
11.2.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2027)
11.2.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2027)
11.3 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type
11.4 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Tuberculosis Vaccine Treatment Supply Chain Analysis
12.2 Tuberculosis Vaccine Treatment Key Raw Materials and Upstream Suppliers
12.3 Tuberculosis Vaccine Treatment Clients Analysis
12.4 Tuberculosis Vaccine Treatment Sales Channel and Sales Model Analysis
12.4.1 Tuberculosis Vaccine Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Tuberculosis Vaccine Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Tuberculosis Vaccine Treatment Distributors
13 Market Dynamics
13.1 Tuberculosis Vaccine Treatment Market Drivers
13.2 Tuberculosis Vaccine Treatment Market Opportunities
13.3 Tuberculosis Vaccine Treatment Market Challenges
13.4 Tuberculosis Vaccine Treatment Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Immune Vaccine
    Table 3. Major Manufacturers of Therapy Vaccine
    Table 4. Global Tuberculosis Vaccine Treatment Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 5. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million): 2021 VS 2027
    Table 6. Global Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose)
    Table 7. Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2022-2027) & (K Dose)
    Table 8. Global Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & (US$ Million)
    Table 9. Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 10. Global Tuberculosis Vaccine Treatment Sales by Manufacturer (2016-2021) & (K Dose)
    Table 11. Global Tuberculosis Vaccine Treatment Sales Share by Manufacturer (2016-2021)
    Table 12. Tuberculosis Vaccine Treatment Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 13. Tuberculosis Vaccine Treatment Revenue Share by Manufacturer (2016-2021)
    Table 14. Key Manufacturers Tuberculosis Vaccine Treatment Price (2016-2021) & (USD/K Dose)
    Table 15. Ranking of Global Top Tuberculosis Vaccine Treatment Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Global Tuberculosis Vaccine Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 17. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Treatment as of 2020)
    Table 18. Tuberculosis Vaccine Treatment Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Tuberculosis Vaccine Treatment Product Type
    Table 20. Date of International Manufacturers Enter into Tuberculosis Vaccine Treatment Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Merck Corporation Information
    Table 23. Merck Description and Business Overview
    Table 24. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 25. Merck Tuberculosis Vaccine Treatment Product
    Table 26. Merck Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 27. Merck Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 28. Merck Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 29. Merck Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Sales Channel
    Table 30. Merck Recent Development
    Table 31. Japan BCG Lab Corporation Information
    Table 32. Japan BCG Lab Description and Business Overview
    Table 33. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 34. Japan BCG Lab Tuberculosis Vaccine Treatment Product
    Table 35. Japan BCG Lab Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 36. Japan BCG Lab Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 37. Japan BCG Lab Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 38. Japan BCG Lab Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Sales Channel
    Table 39. Japan BCG Lab Recent Development
    Table 40. Serum Institute of India Corporation Information
    Table 41. Serum Institute of India Description and Business Overview
    Table 42. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 43. Serum Institute of India Tuberculosis Vaccine Treatment Product
    Table 44. Serum Institute of India Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 45. Serum Institute of India Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 46. Serum Institute of India Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 47. Serum Institute of India Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Sales Channel
    Table 48. Serum Institute of India Recent Development
    Table 49. AJ Vaccines Corporation Information
    Table 50. AJ Vaccines Description and Business Overview
    Table 51. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 52. AJ Vaccines Tuberculosis Vaccine Treatment Product
    Table 53. AJ Vaccines Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 54. AJ Vaccines Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 55. AJ Vaccines Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 56. AJ Vaccines Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Sales Channel
    Table 57. AJ Vaccines Recent Development
    Table 58. BioFarma Corporation Information
    Table 59. BioFarma Description and Business Overview
    Table 60. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 61. BioFarma Tuberculosis Vaccine Treatment Product
    Table 62. BioFarma Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 63. BioFarma Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 64. BioFarma Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 65. BioFarma Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Sales Channel
    Table 66. BioFarma Recent Development
    Table 67. GreenSignal Bio Pharma Corporation Information
    Table 68. GreenSignal Bio Pharma Description and Business Overview
    Table 69. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 70. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product
    Table 71. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 72. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 73. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 74. GreenSignal Bio Pharma Recent Development
    Table 75. China National Biotec Corporation Information
    Table 76. China National Biotec Description and Business Overview
    Table 77. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 78. China National Biotec Tuberculosis Vaccine Treatment Product
    Table 79. China National Biotec Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 80. China National Biotec Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 81. China National Biotec Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 82. China National Biotec Recent Development
    Table 83. Biomed Lublin Corporation Information
    Table 84. Biomed Lublin Description and Business Overview
    Table 85. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 86. Biomed Lublin Tuberculosis Vaccine Treatment Product
    Table 87. Biomed Lublin Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 88. Biomed Lublin Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 89. Biomed Lublin Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 90. Biomed Lublin Recent Development
    Table 91. Taj Pharmaceuticals Corporation Information
    Table 92. Taj Pharmaceuticals Description and Business Overview
    Table 93. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 94. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product
    Table 95. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 96. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 97. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 98. Taj Pharmaceuticals Recent Development
    Table 99. Ataulpho de Paiva Corporation Information
    Table 100. Ataulpho de Paiva Description and Business Overview
    Table 101. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 102. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product
    Table 103. Ataulpho de Paiva Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 104. Ataulpho de Paiva Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 105. Ataulpho de Paiva Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 106. Ataulpho de Paiva Recent Development
    Table 107. IVAC Corporation Information
    Table 108. IVAC Description and Business Overview
    Table 109. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 110. IVAC Tuberculosis Vaccine Treatment Product
    Table 111. IVAC Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 112. IVAC Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 113. IVAC Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 114. IVAC Recent Development
    Table 115. Queen Saovabha Mem. Inst Corporation Information
    Table 116. Queen Saovabha Mem. Inst Description and Business Overview
    Table 117. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 118. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product
    Table 119. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 120. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 121. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 122. Queen Saovabha Mem. Inst Recent Development
    Table 123. Microgen Corporation Information
    Table 124. Microgen Description and Business Overview
    Table 125. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 126. Microgen Tuberculosis Vaccine Treatment Product
    Table 127. Microgen Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Product
    Table 128. Microgen Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Application
    Table 129. Microgen Tuberculosis Vaccine Treatment Revenue (US$ Million) and Market Share by Geographic Area
    Table 130. Microgen Recent Development
    Table 131. Global Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
    Table 132. Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2022-2027) & (K Dose)
    Table 133. Global Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & (US$ Million)
    Table 134. Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 135. Global Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
    Table 136. Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2022-2027) & (K Dose)
    Table 137. Global Tuberculosis Vaccine Treatment Revenue by Application (2016-2021) & (US$ Million)
    Table 138. Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 139. North America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 140. North America Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose)
    Table 141. North America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 142. North America Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 143. North America Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
    Table 144. North America Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
    Table 145. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose)
    Table 146. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2022-2027) & (K Dose)
    Table 147. Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2016-2027) & (US$ Million)
    Table 148. Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2022-2027) & (US$ Million)
    Table 149. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
    Table 150. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
    Table 151. Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 152. Europe Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose)
    Table 153. Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 154. Europe Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 155. Europe Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
    Table 156. Europe Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
    Table 157. Latin America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 158. Latin America Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose)
    Table 159. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 160. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 161. Latin America Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
    Table 162. Latin America Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
    Table 163. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 164. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose)
    Table 165. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 166. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 167. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
    Table 168. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
    Table 169. Tuberculosis Vaccine Treatment Key Raw Materials, Industry Status and Trend
    Table 170. Tuberculosis Vaccine Treatment Key Raw Materials and Upstream Suppliers
    Table 171. Tuberculosis Vaccine Treatment Clients Status and Trend
    Table 172. Tuberculosis Vaccine Treatment Typical Clients
    Table 173. Tuberculosis Vaccine Treatment Distributors
    Table 174. Key Drivers: Impact Analysis (2022-2027)
    Table 175. Tuberculosis Vaccine Treatment Market Drivers
    Table 176. Tuberculosis Vaccine Treatment Market Opportunities
    Table 177. Tuberculosis Vaccine Treatment Market Challenges
    Table 178. Tuberculosis Vaccine Treatment Market Restraints
    Table 179. Tuberculosis Vaccine Treatment Porter’s Five Forces Analysis
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tuberculosis Vaccine Treatment Product Picture
    Figure 2. Global Tuberculosis Vaccine Treatment Sales Market Share by Type in 2021 & 2027
    Figure 3. Immune Vaccine Product Picture
    Figure 4. Therapy Vaccine Product Picture
    Figure 5. Global Tuberculosis Vaccine Treatment Sales Market Share by Application in 2021 & 2027
    Figure 6. Self-Procurement Examples
    Figure 7. UNICEF Examples
    Figure 8. Other Examples
    Figure 9. Tuberculosis Vaccine Treatment Report Years Considered
    Figure 10. Global Tuberculosis Vaccine Treatment Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Tuberculosis Vaccine Treatment Market Size 2016-2027 (US$ Million)
    Figure 12. Global Tuberculosis Vaccine Treatment Sales 2016-2027 (K Units)
    Figure 13. Global Tuberculosis Vaccine Treatment Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Region (2016-2027)
    Figure 15. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2027)
    Figure 16. Global Tuberculosis Vaccine Treatment Sales Share by Manufacturer in 2020
    Figure 17. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 18. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Type (2016-2027)
    Figure 19. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Type (2016-2027)
    Figure 20. Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 21. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Application (2016-2027)
    Figure 22. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Application (2016-2027)
    Figure 23. Tuberculosis Vaccine Treatment Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 24. North America Tuberculosis Vaccine Treatment Revenue 2016-2027 (US$ Million)
    Figure 25. North America Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
    Figure 26. North America Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
    Figure 27. Asia-Pacific Tuberculosis Vaccine Treatment Revenue 2016-2027 (US$ Million)
    Figure 28. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2027)
    Figure 29. Asia-Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2027)
    Figure 30. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
    Figure 31. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
    Figure 32. Europe Tuberculosis Vaccine Treatment Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 33. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2027)
    Figure 34. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2027)
    Figure 35. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
    Figure 36. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
    Figure 37. Latin America Tuberculosis Vaccine Treatment Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 38. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2027)
    Figure 39. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
    Figure 40. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
    Figure 41. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
    Figure 42. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 43. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2027)
    Figure 44. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2027)
    Figure 45. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
    Figure 46. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
    Figure 47. Tuberculosis Vaccine Treatment Supply Chain (Upstream and Downstream Market)
    Figure 48. Global Production Market Share of Tuberculosis Vaccine Treatment Raw Materials by Region in 2020
    Figure 49. Tuberculosis Vaccine Treatment Distribution Channels
    Figure 50. Global Tuberculosis Vaccine Treatment Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 51. Global Tuberculosis Vaccine Treatment Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 52. Porter's Five Forces Analysis
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows multiple user to access the PDF.

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart